Skip to main content
. 2017 Dec 18;110(6):638–648. doi: 10.1093/jnci/djx253

Figure 1.

Figure 1.

Nomograms for (A) overall survival and (B) progression-free survival. See the Supplementary Materials (available online) for instructions for use. BMI = body mass index (mg/kg2); BRAF = BRAF gene status; KRAS = Kirsten rat sarcoma gene; Meta count = number of metastatic sites; MT = mutant; OS = overall survival; Performance status = Eastern Cooperative Oncology Group/World Health Organization performance status (0,1,2); PFS = progression-free survival; Prior chemo = previous (adjuvant) chemotherapy; WT = wild-type.